参考文献/References:
[1] WHO.WHO global action plan for the prevention and control of noncommunicable diseases 2013-2020.Geneva:World Health Organization,2013.
[2] Brown IJ,Tzoulaki I,Candeias V,et al.Salt intakes around the world: implications for public health[J].Int J Epidemiol,2009,38(3):791-813.DOI:10.1093/ije/dyp139.
[3] Yan L,Guo X,Wang H,et al.Population-based association between urinary excretion of sodium, potassium and its ratio with albuminuria in Chinese[J].Asia Pac J Clin Nutr,2016,25(4):785-797.DOI:10.6133/apjcn.092015.33.
[4] Oh SW,Han KH,Han SY,et al.Association of sodium excretion with metabolic syndrome, insulin resistance, and body fat[J].Medicine(Baltimore),2015,94(39):e1650.DIO:10.1097/MD.0000000000001650.
[5] Suckling RJ,He FJ,Macgregor GA.Altered dietary salt intake for preventing and treating diabetic kidney disease[J].Cochrane Database Syst Rev,2010,(12):CD006763.DOI:10.1002/14651858.CD006763.pub2.
[6] Suckling RJ,He FJ,Markandu ND,et al.Modest salt reduction lowers blood pressure and albumin excretion in impaired glucose tolerance and type 2 diabetes mellitus:a randomized double-blind trial[J].Hypertension,2016,67(6):1189-1195. DOI:10.1161/HYPERTENSIONAHA.115.06637.
[7] Ohta Y,Tsuchihashi T,Kiyohara K,et al.High salt intake promotes a decline in renal function in hypertensive patients:a 10-year observational study[J].Hypertens Res,2013,36(2):172-176.DOI:10.1038/hr.2012.155.
[8] Nomura K,Asayama K,Jacobs L,et al.Renal function in relation to sodium intake: a quantitative review of the literature[J].Kidney Int,2017,92(1):67-78.DOI:10.1016/j.kint.2016.11.032.
[9] Luik PT,Hoogenberg K,Van Der Kleij FG,et al.Short-term moderate sodium restriction induces relative hyperfiltration in normotensive normoalbuminuric type Ⅰ diabetes mellitus[J].Diabetologia,2002,45(4):535-541.DOI:10.1007/s00125-001-0763-8.
[10] Kanauchi N,Ookawara S,Ito K,et al.Factors affecting the progression of renal dysfunction and the importance of salt restriction in patients with type 2 diabetic kidney disease[J].Clin Exp Nephrol,2015,19(6):1120-1126.DOI:10.1007/s10157-015-1118-y.
[11] Jaikumkao K,Pongchaidecha A,Chatsudthipong V,et al.The roles of sodium-glucose cotransporter 2 inhibitors in preventing kidney injury in diabetes[J].Biomed Pharmacother,2017,94:176-187.DOI:10.1016/j.biopha.2017.07.095.
[12] Vallon V,Schroth J,Satriano J,et al.Adenosine A(1)receptors determine glomerular hyperfiltration and the salt paradox in early streptozotocin diabetes mellitus[J].Nephron Physiol,2009,111(3):30-38.DOI:10.1159/000208211.
[13] Miracle CM,Rieg T,Mansoury H,et al.Ornithine decarboxylase inhibitor eliminates hyperresponsiveness of the early diabetic proximal tubule to dietary salt[J].Am J Physiol Renal Physiol,2008,295(4):F995-F1002.DOI:10.1152/ajprenal.00491.2007.
[14] Delanaye P,Scheen AJ.Preventing and treating kidney disease in patients with type 2 diabetes[J].Expert Opin Pharmacother,2019,20(3):277-294.DOI:10.1080/14656566.2018.1551362.
[15] Zhao Y,Gao P,Sun F,et al.Sodium intake regulates glucose homeostasis through the PPARδ/adiponectin-mediated SGLT2 pathway[J].Cell Metab,2016,23(4):699-711.DOI:10.1016/j.cmet.2016.02.019.
[16] Yang X,Xiao X,Wang H,et al.Renoprotective effect of danhong injection on streptozotocin-induced diabetic ratsthrough a peroxisome proliferator-activated receptor γ mediated pathway[J].Evid Based Complement Alternat Med,2018,2018:3450141.DOI:10.1155/2018/3450141.
[17] Ibarra ME,Albertoni Borghese MF,Majowicz MP,et al.Concerted regulation of renal plasma flow and glomerular filtration rate by renaldopamine and NOS I in rats on high salt intake[J].Physiol Rep,2017,5(6).pii: e13202. DOI:10.14814/phy2.13202.
[18] Garagliano JM,Katsurada A,Miyata K,et al.Advanced glycation end products stimulate angiotensinogen production in renal proximal tubular cells[J].Am J Med Sci,2019,357(1):57-66.DOI:10.1016/j.amjms.2018.10.008.
[19] Schnermann J.Concurrent activation of multiple vasoactive signaling pathways in vasoconstriction caused by tubuloglomerular feedback: a quantitative assessment[J].Annu Rev Physiol,2015,77:301-322.DOI:10.1146/annurev-physiol-021014-071829.
[20] Rust P, Ekmekcioglu C. Impact of salt intake on the pathogenesis and treatment of hypertension[J].Adv Exp Med Biol,2017,956:61-84.DOI:10.1007/5584_2016_147.
[21] Regoli D,Gobeil F.Kallikrein-kinin system as the dominant mechanism to counteract hyperactive renin-angiotensin system[J].Can J Physiol Pharmacol,2017,95(10):1117-1124.DOI:10.1139/cjpp-2016-0619.
[22] Schweda F.Salt feedback on the renin-angiotensin-aldosterone system[J].Pflugers Arch,2015,467(3):565-576.DOI:10.1007/s00424-014-1668-y.
[23] Leenen FHH,Blaustein MP,Hamlyn JM.Update on angiotensin Ⅱ: new endocrine connections between the brain, adrenal glands and the cardiovascular system[J].Endocr Connect,2017,6(7):R131-R145.DOI:10.1530/EC-17-0161.
[24] Walsh KR,Kuwabara JT,Shim JW,et al.Norepinephrine-evoked salt-sensitive hypertension requires impaired renal sodium chloride cotransporter activity in Sprague-Dawley rats[J].Am J Physiol Regul Integr Comp Physiol,2016,310(2):R115-R124.DOI:10.1152/ajpregu.00514.2014.
[25] Berger RC,Vassallo PF,Crajoinas Rde O,et al.Renal effects and underlying molecular mechanisms of long-term salt content diets in spontaneously hypertensive rats[J].PLoS One,2015,10(10):e0141288.DOI:10.1371/journal.pone.0141288.
[26] Birk C,Richter K,Huang DY,et al.The salt paradox of the early diabetic kidney is independent of renal innervation[J].Kidney Blood Press Res,2003,26(5-6):344-350.DOI:10.1159/000073941.
[27] Vallon V,Schroth J,Satriano J,et al.Adenosine A(1)receptors determine glomerular hyperfiltration and the salt paradox in early streptozotocin diabetes mellitus[J].Nephron Physiol,2009,111(3):30-38.DOI:10.1159/000208211.
[28] Williams VR,Scholey JW.Angiotensin-converting enzyme 2 and renal disease[J].Curr Opin Nephrol Hypertens,2018,27(1):35-41.DOI:10.1097/MNH.0000000000000378.
[29] Østergaard MV,Pinto V,Stevenson K,et al.DBA2J db/db mice are susceptible to early albuminuria and glomerulosclerosis that correlate with systemic insulin resistance[J].Am J Physiol Renal Physiol,2017,312(2):F312-F321.DOI:10.1152/ajprenal.00451.2016.
[30] Jaldin-Fincati JR,Pavarotti M,Frendo-Cumbo S,et al.Update on GLUT4 vesicle traffic: a cornerstone of insulin action[J].Trends Endocrinol Metab,2017,28(8):597-611.DOI:10.1016/j.tem.2017.05.002.
[31] Graus-Nunes F,Souza-Mello V.The renin-angiotensin system as a target to solve the riddle of endocrine pancreashomeostasis[J].Biomed Pharmacother,2019,109:639-645.DOI:10.1016/j.biopha.2018.10.191.
[32] Premilovac D,Richards SM,Rattigan S,et al.A vascular mechanism for high-sodium-induced insulin resistance in rats[J].Diabetologia,2014,57(12):2586-2595.DOI:10.1007/s00125-014-3373-y.
[33] Stevens AL,Ferferieva V,Bito V,et al.Exercise improves cardiac function and attenuates insulin resistance in Dahl salt-sensitive rats[J].Int J Cardiol,2015,186:154-160.DOI:10.1016/j.ijcard.2015.03.094.
[34] Oh H,Lee HY,Jun DW,et al.Low salt diet and insulin resistance[J].Clin Nutr Res,2016,5(1):1-6.DOI:10.7762/cnr.2016.5.1.1.
[35] Iwasa N,Emoto N,Widyantoro B,et al.Knockout of endothelin-1 in vascular endothelial cells protects against insulinresistance induced by high-salt diet in mice[J].Kobe J Med Sci,2010,56(2):E85-E91.
[36] Perry CG,Palmer T,Cleland SJ,et al.Decreased insulin sensitivity during dietary sodium restriction is not mediated by effects of angiotensin Ⅱ on insulin action[J].Clin Sci(Lond),2003,105(2):187-194.DOI:10.1042/CS20020320.
[37] Zhao Y,Gao P,Sun F,et al.Sodium intake regulates glucose homeostasis through the PPARδ/adiponectin-mediated SGLT2 pathway[J].Cell Metab,2016,23(4):699-711.DOI:10.1016/j.cmet.2016.02.019.
[38] Kern M,Klöting N,Mark M,et al.The SGLT2 inhibitor empagliflozin improves insulin sensitivity in db/db mice both as monotherapy and in combination with linagliptin[J].Metabolism,2016,65(2):114-123.DOI:10.1016/j.metabol.2015.10.010.
[39] Chan SMH,Lau YS,Miller AA,et al.Angiotensin Ⅱ causes β-cell dysfunction through an ER stress-induced proinflammatory response[J].Endocrinology,2017,158(10):3162-3173. DOI:10.1210/en.2016-1879.
[40] Oudot C,Lajoix AD,Jover B,et al.Dietary sodium restriction prevents kidney damage in high fructose-fed rats[J].Kidney Int,2013,83(4):674-683.DOI:10.1038/ki.2012.478.
[41] Lara LS,McCormack M,Semprum-Prieto LC,et al.AT1 receptor-mediated augmentation of angiotensinogen, oxidative stress, and inflammation in ANG Ⅱ-salt hypertension[J].Am J Physiol Renal Physiol,2012,302(1):F85-F94.DOI:10.1152/ajprenal.00351.2011.
[42] Singh P,Castillo A,Islam MT,et al.Evidence for prohypertensive, proinflammatory effect of interleukin-10 during chronic high salt intake in the condition of elevated angiotensin Ⅱ level[J].Hypertension,2017,70(4):839-845.DOI:10.1161/HYPERTENSIONAHA.117.09401.
[43] Singh P,Bahrami L,Castillo A,et al.TNF-α type 2 receptor mediates renal inflammatory response to chronic angiotensin Ⅱ administration with high salt intake in mice[J].Am J Physiol Renal Physiol,2013,304(7):F991-F999.DOI:10.1152/ajprenal.00525.2012.
[44] Li X,Xing W,Wang Y,et al.Upregulation of caveolin-1 contributes to aggravated high-salt diet-induced endothelial dysfunction and hypertension in type 1 diabetic rats[J].Life Sci,2014,113(1-2):31-39.DOI:10.1016/j.lfs.2014.07.027.
相似文献/References:
[1]李春睿,王静,陈峰,等.GLP-1受体激动剂对糖尿病患者肾功能的影响[J].国际内分泌代谢杂志,2014,(06):401.[doi:10.3760/cma.j.issn.1673-4157.2014.06.011]
Li Chunrui*,Wang Jing,Chen Feng,et al.Effects of GLP-1 receptor agonists on renal function of diabetics[J].International Journal of Endocrinology and Metabolism,2014,(03):401.[doi:10.3760/cma.j.issn.1673-4157.2014.06.011]
[2]黄珊珊,鲁一兵.长链非编码RNA与糖尿病[J].国际内分泌代谢杂志,2015,(04):271.[doi:10.3760/cma.j.issn.1673-4157.2015.04.016]
Huang Shanshan*,Lu Yibing..Long non-coding RNA and diabetes mellitus[J].International Journal of Endocrinology and Metabolism,2015,(03):271.[doi:10.3760/cma.j.issn.1673-4157.2015.04.016]
[3]高瑞霄,姚朱华,冯凭,等.尿8-羟基脱氧鸟苷在2型糖尿病及糖尿病合并冠心病患者中的临床意义[J].国际内分泌代谢杂志,2014,(05):295.[doi:10.3760/cma.j.issn.1673-4157.2014.05.002]
Gao Ruixiao*,Yao Zhuhua,Feng Ping,et al.The clinical significance of urinary 8-hydroxy deoxyguanosine in patients with type 2 diabetes mellitus and diabetic patients with coronary heart disease[J].International Journal of Endocrinology and Metabolism,2014,(03):295.[doi:10.3760/cma.j.issn.1673-4157.2014.05.002]
[4]郑佳,肖新华.葡萄糖稳态的中枢调控作用机制
——2014年美国糖尿病协会“杰出科学成就奖”
演讲报告解读[J].国际内分泌代谢杂志,2014,(05):305.[doi:10.3760/cma.j.issn.1673-4157.2014.05.004]
Zheng Jia,Xiao Xinhua.The mechanisms of central nervous system in the control of glucose homeostasis--A summary of 2014 ADA "Outstanding Scientific Achievement Award" Lecture[J].International Journal of Endocrinology and Metabolism,2014,(03):305.[doi:10.3760/cma.j.issn.1673-4157.2014.05.004]
[5]唐勤,邵莉.蛋白乙酰化与胰岛素分泌[J].国际内分泌代谢杂志,2014,(05):313.[doi:10.3760/cma.j.issn.1673-4157.2014.05.007]
Tang Qin,Shao Li..Protein acetylation and insulin secretion[J].International Journal of Endocrinology and Metabolism,2014,(03):313.[doi:10.3760/cma.j.issn.1673-4157.2014.05.007]
[6]卢婷婷,任思佳,沈捷.人群迁徙对糖尿病患病率的影响及其相关因素[J].国际内分泌代谢杂志,2014,(05):327.[doi:10.3760/cma.j.issn.1673-4157.2014.05.011]
Lu Tingting,Ren Sijia,Shen Jie..Impact of migration on prevalence of diabetes and risk factors[J].International Journal of Endocrinology and Metabolism,2014,(03):327.[doi:10.3760/cma.j.issn.1673-4157.2014.05.011]
[7]包薇萍,陈国芳,刘超.DPP-4抑制剂的肾保护作用[J].国际内分泌代谢杂志,2014,(05):337.[doi:10.3760/cma.j.issn.1673-4157.2014.05.014]
Bao Weiping,Chen Guofang,Liu Chao..Renal protective effects of dipeptidyl peptidase-4 inhibitors[J].International Journal of Endocrinology and Metabolism,2014,(03):337.[doi:10.3760/cma.j.issn.1673-4157.2014.05.014]
[8]孟庆冬,陶红.巨噬细胞凋亡与糖尿病动脉粥样硬化[J].国际内分泌代谢杂志,2014,(05):340.[doi:10.3760/cma.j.issn.1673-4157.2014.05.015]
Meng Qingdong,Tao Hong..Macrophage apoptosis and diabetic atherosclerosis[J].International Journal of Endocrinology and Metabolism,2014,(03):340.[doi:10.3760/cma.j.issn.1673-4157.2014.05.015]
[9]赵荷珺 洪天配.胰高血糖素样肽-1类药物与胰腺安全性[J].国际内分泌代谢杂志,2015,(05):319.[doi:DOI:10.3760/cma.j.issn.1673-4157.2015.05.008]
Zhao Hejun*,Hong Tianpei..Glucagon-like peptide-1-based therapies and pancreatic safety[J].International Journal of Endocrinology and Metabolism,2015,(03):319.[doi:DOI:10.3760/cma.j.issn.1673-4157.2015.05.008]
[10]吕丹 李晓思 陈树春 王泽普.Betatrophin:糖尿病再生治疗的新希望[J].国际内分泌代谢杂志,2015,(05):351.[doi:DOI:10.3760/cma.j.issn.1673-4157.2015.05.016]
Lyu Dan*,Li Xiaosi,Chen Shuchun,et al.Betatrophin:new hope for regeneration therapy of diabetes[J].International Journal of Endocrinology and Metabolism,2015,(03):351.[doi:DOI:10.3760/cma.j.issn.1673-4157.2015.05.016]